Licensing deal signed with Tepnel Life Sciences

Abcam has extended its global licensing agreement with Tepnel Life Sciences. The two year deal means that Abcam will continue to distribute Tepnel's Diaclone range of products to scientists worldwide.

The agreement supports Abcam's growing range of non-antibody products, which now includes proteins, peptides, kits, slides and lysates.

Over 500 kits now available

Check out our range of kits

Read more about Abcam's proteins and peptides

Read more about Abcam's range of ELISA, ELISPOT and ELIPAIR kits


back to news list

©1998-2010 Abcam plc. All rights reserved. Abcam plc is incorporated in the UK, its main country of operations is the UK.
Share price and news information on this site is updated dynamically from external data feeds. Static content was last updated on 9 August 2010